Table 2.
Patient demographics, method of induction, maternal and fetal outcome (NMH 2016)
| Group 2A | Group 4A | 95% CI | p-value | |
|---|---|---|---|---|
| Age > =35 years | 439/1339 (32.78%) | 531/1005 (52.83%) | 15.9 to 23.9 | P < 0.0001 |
| BMI= > 30 | 166/1339 (12.39%) | 145/1005 (14.42%) | −0.7 to 4.8 | P = 0.1577 |
| Prostaglandin gel/Propess | 666/1339 (49.73%) | 348/1005 (34.62%) | 11 to 19 | P < 0.0001 |
| Oxytocin | 961/1339 (71.76%) | 323/1005 (32.13%) | 35.8 to 43.3 | P < 0.0001 |
| Artificial rupture of membranes | 882/1339 (65.87%) | 851/1005 (84.67%) | 15.3 to 22.1 | P < 0.0001 |
| Fetal blood sampling | 380/1339 (28.37%) | 68/1005 (6.76%) | 18.6 to 24.4 | P < 0.0001 |
| Vaginal operative delivery | 392/1339 (29.27%) | 57/1005 (5.67%) | 20.7 to 26.3 | P < 0.0001 |
| Full dilatation caesarean section | 34/1339 (2.53%) | 2/1005 (0.19%) | 1.4 to 3.2 | P < 0.0001 |
| PPH= > 1000 ml | 63/1339 (4.70%) | 27/1005 (2.68%) | 0.4 to 3.5 | P = 0.0127 |
| HIE | 5/1339 (0.37%) | 0/1005 (0%) | −0.1to 0.9 | P = 0.0448 |
| Blood transfusion | 45/1339 (3.36%) | 9/1005 (0.89%) | 1.3 to 3.6 | P = 0.0001 |
| OASIS | 29/1339 (2.16%) | 12/1005 (1.19%) | −0.1 to 2.1 | P = 0.0694 |
| Apgar< 7 at 5 min. | 20/1339 (1.49%) | 8/1005 (0.79%) | −0.2 to 1.5 | P = 0.1235 |
| Cord pH < 7.0 | 5/1339 (0.37%) | 2/1005 (0.19%) | −0.3 to 0.7 | P = 0.3920 |
| Admission to Neonatal unit | 405/1339 (30.24%) | 145/1005 (14.42%) | 12.4 to 19 | P < 0.0001 |
| Babies> = 4 kg | 242/1339 (18.07%) | 264/1005 (26.26%) | 4.8 to 11.6 | P < 0.0001 |
| Episiotomy | 570/1339 (42.56%) | 85/1005 (8.45%) | 30.8 to 37.1 | P < 0.0001 |
| Epidural | 1023/1339 (76.40%) | 517/1005 (51.44%) | 21.1 to 28.7 | P < 0.0001 |
| Electronic monitoring | 1238/1339 (92.45%) | 913/1005 (90.84%) | −0.5 to 4 | P = 0.1384 |
| Length of labour > 12 h | 103/1339 (7.69%) | 9/1005 (0.89%) | 5.2 to 8.4 | P < 0.0001 |